Reported 5 months ago
Cathie Wood, the CEO of ARK Invest, recently increased her holdings in Adaptive Biotechnologies, Intellia Therapeutics, and Shopify despite their stock values declining by 16% to 29% in 2024. Shopify's shares are down 27% this year due to lower-than-expected growth projections, but analysts foresee revenue and profitability growth ahead. Intellia Therapeutics, specializing in CRISPR-based treatments, has seen a 16% decrease this year despite good earnings, while Adaptive Biotechnologies, despite a 50% stock value drop, showed positive financial results recently. Wood's strategic investments in these growth companies reflect her confidence in their potential amidst market volatility.
Source: YAHOO